Skip to main content
SpringerLink
Log in

Effects of Somatostatin and Octreotide on Pancreatic Function

  • Conference paper
Standards in Pancreatic Surgery

  • 182 Accesses

Abstract

The tetradecapeptide hormone somatostatin was first detected in the ovine hypothalamus and was described as growth hormone release inhibitor by Brazeau et al. [13]. Numerous studies have been performed to elucidate effects and possible therapeutic uses of this hormone. More recently analogs of somatostatin were synthesized and investigated with different aims in various animal and human studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Alberti KG, Christensen NJ, Christensen SE et al. (1973) Inhibition of insulin secretion by somatostatin. Lancet 2:1299–1301

    Article  PubMed  CAS  Google Scholar 

  2. Arnold R, Creutzfeldt W (1975) Hemmung der Pentagastrin-induzierten Säuresekretion des Magens beim Menschen durch Somatostatin. Dtsch Med Wschr 100:1014–1016

    PubMed  CAS  Google Scholar 

  3. Arnold R, Lankisch PG (1980) Somatostatin and the gastrointestinal tract. Clin Gastroenterol 9:733–753

    PubMed  CAS  Google Scholar 

  4. Baidissera FGA, Holst JJ, Jensen SL, Krarup T (1985) Distribution and molecular forms of peptides containing somatostatin immunodeterminants in extracts from the entire gastrointestinal tract of man and pig. Biochim Biophys Acta 838:132–143

    Article  Google Scholar 

  5. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1982) SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sei 31:1133–1140

    Article  CAS  Google Scholar 

  6. Baxter JN, Jenkins SA, Day DW et al. (1985) Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally-induced acute pancreatitis in the rat. Br J Surg 72:382–385

    Article  PubMed  CAS  Google Scholar 

  7. Baxter JN, Ellenbogen S, Roberts N, Mackie CR, Jenkins SA (1988) The effects of a somatostatin analogue, SMS 201–995, on pancreatic secretion in the pig and in man. Surg Res Comm 4:215—228

    Google Scholar 

  8. Besser GM, Mortimer CH, McNeilly AS, Thorner MO, Batistoni GA, Bloom SR, Rastrup KW, Hanssen KF, Hall R, Coy DH, Kastin AJ, Schally AV (1974) Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones. Br Med J 4:622–627

    Article  PubMed  CAS  Google Scholar 

  9. Bloom SR, Mortimer CH, Thorner MO, Besser GM, Hall R, Gomez-Pan A, Roy M, Russell RCG, Coy DH, Kastin AJ, Schally AV (1974) Inhibition of gastrin and gastric acid secretion by growth-hormone release-inhibiting hormone. Lancet 2:1106–1109

    Article  PubMed  CAS  Google Scholar 

  10. Bloom SR, Ralphs KN, Besser GM et al. (1975) Effect of somatostatin on motilin levels and gastric emptying. Gut 16:834

    Article  PubMed  CAS  Google Scholar 

  11. Boden G, Sivitz MC, Owen OE, Essa-Koumar N, Landor JH (1975) Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 190:163–165

    Article  PubMed  CAS  Google Scholar 

  12. Bordas JM, Toledo V, Mondelo F, Rodes J (1988) Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangiopancreatography. Horm Res 29:106–108

    Article  PubMed  CAS  Google Scholar 

  13. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive growth hormone. Science 179:77–79

    Article  PubMed  CAS  Google Scholar 

  14. Buffa R, Chayvialle JA, Fontana P, Usellini L, Capeila C, Solcia E (1979) Parafollicular cells of rabbit thyroid store both calcitonin and somatostatin and resemble gut D cells ultrastructurally. Histochemistry 62:281–288

    Article  PubMed  CAS  Google Scholar 

  15. Chariot J, Roze C, Vaille C, Debray C (1978) Effects of somatostatin on the external secretion of the pancreas of the rat. Gastroenterology 75:832–837

    PubMed  CAS  Google Scholar 

  16. Choi TK, Mok F, Zhan WH, Fan ST, Lai ECS, Wong J (1989) Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut 30:223–227

    Article  PubMed  CAS  Google Scholar 

  17. Christiansen J, Yotis A (1986) The role of somatostatin and a long-acting analogue, SMS 201–995, in acute bleeding due to peptic ulceration. Scand J Gastroenterol 21[Suppl 119]:109–114

    Article  Google Scholar 

  18. Comi RJ, Maton PN, Go VLW (1989) Somaostatin and somatostatin analogue (SMS 201–995) in treatment of hormonesecreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 110:35–50

    PubMed  Google Scholar 

  19. Conlon JM, Whittaker J, Hammond V, Alberti K (1981) Metabolism of somatostatin and its analogues by the liver. Biochim Biophys Acta 677:234–242

    Article  PubMed  CAS  Google Scholar 

  20. Cooper MM, Wright FH, Smith JL, Corry RJ (1989) Successful treatment of a high-output fistula with a somatostatin analogue following pancreas transplantation. Transplant Proc 21:3738–3741

    PubMed  CAS  Google Scholar 

  21. Creutzfeldt W, Lankisch PG, Fölsch UR (1975) Hemmung der Sekretin- und Cholecystokinin-Pankreozymin-induzierten Saft- und Enzymsekretion des Pankreas und der Gallenblasenkontraktion beim Menschen durch Somatostatin. Dtsch Med Wochenschr 100:1135–1138

    PubMed  CAS  Google Scholar 

  22. Creutzfeldt W, Lembcke B, Fölsch UR, Schlieser S, Koop I (1987) Effect of somatostatin analogue (SMS 201–995, Sandostatin) on pancreatic secretion in humans. Am J Med 82[Suppl 5B]:49–54

    Article  PubMed  CAS  Google Scholar 

  23. D’Amico D, Favia G, Biasiato R, Casaccia M, Falcone F, Fersini M, Marrano D, Napolitano F, Oliviero S, Rodolico A (1990) The use of somatostatin in acute pancreatitis - results of a multicenter trial. Hepatogastroenterol 37:92–98

    Google Scholar 

  24. Degertekin H, Ertan A, Akdamar K et al. (1985) Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice. Peptides 6:1245–1247698

    Google Scholar 

  25. Delbert Kwan BA, Aufses AH (1989) Short-term administration of SMS 201- 995 in the management of an external pancreatic fistula. Am J Gastroenterol 84:326–328

    Google Scholar 

  26. De Rai P, Franciosi C, Confalonieri GM et al. (1988) Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop. Int J Pancreatol 3:367–374

    PubMed  Google Scholar 

  27. Dollinger HC, Raptis S, Pfeiffer EF (1976) Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res 8:74–78

    Article  PubMed  CAS  Google Scholar 

  28. Domschke S, Domschke W, Rosch W (1977) Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: a study with pure pancreatic juice. Scand J Gastroenterol 12:59–63

    PubMed  CAS  Google Scholar 

  29. Eide R, Hökfelt T, Johansson O, Schultzberg M, Efendic S, Luft R (1978) Cellular localization of somatostatin. Metabolism 27[Suppl 1]:1151—1159

    Google Scholar 

  30. Fedorak RN (1989) Long acting somatostatin analogue: Clinical potential for gastrointestinal disease. Can J Gastroenterol 3:77–81

    Google Scholar 

  31. Gomez-Pan A, Reed JD, Albinus M et al. (1975) Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats. Lancet 1:888–890

    Article  PubMed  CAS  Google Scholar 

  32. Gullo L, Priori P, Scorpignato C et al. (1987) Effect of somatostatin-14 on pure human pancreatic secretion. Dig Dis Sei 32:1065–1070

    Article  CAS  Google Scholar 

  33. Gullo L, Pezzelli R, Barbara L (1989) Effect of somatostatin in plasma amino acids uptake by human pancreas. Gastroenterology 97:732–736

    PubMed  CAS  Google Scholar 

  34. Gyr K, Beglinger C, Köhler E, Tratzl U, Keller U, Bloom SR (1987) Circulating somatostatin - a physiological regulator of pancreatic function? J Clin Invest 79:1595–1600

    Article  PubMed  CAS  Google Scholar 

  35. Hanssen LE, Hanssen F, Myren J (1977) Inhibition of secretin release and pancreatic bicarbonate secretion by somatostatin infusion in man. Scand J Gastroenterol 12:391–394

    Article  PubMed  CAS  Google Scholar 

  36. Hild P, Dobroschke J, Henneking K et al. (1986) Treatment of enterocutaneous fistulas with somatostatin. Lancet 2:626

    Article  PubMed  CAS  Google Scholar 

  37. Hopman WPM, van Liessum PA, Pieters GFFM, Smals AGH, Tangerman A, Jansen JBMJ, Rosenbusch G, Lamers CBHW, Kloppenborg PWC (1990)Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201–995). Digestion 45[Suppl l]:72–76

    Article  PubMed  Google Scholar 

  38. Ipp E, Dobbs RE, Arimura A, Vale W, Harris V, Unger RH (1977) Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest 60:760–765

    Article  PubMed  CAS  Google Scholar 

  39. Jenkins SA, Baxter JN, Corbett W et al. (1985) A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage. Br Med J 290:275–278

    Article  CAS  Google Scholar 

  40. Johansson C, Wisen O, Efendic S, Uvnas-Wallensten K (1981) Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22:126–137

    Article  PubMed  CAS  Google Scholar 

  41. Kemmer TP, Malfertheiner P, Büchler M, Frieß H, Meschenmoser L, Ditschuneit H (1992) Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201–995). Aliment Pharmacol Ther 6:41–50

    Article  PubMed  CAS  Google Scholar 

  42. Köhler E, Beglinger C, Dettwiler S, Whitehouse I, Gyr K (1986) Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas 1:154–159

    Article  PubMed  Google Scholar 

  43. Koerker DJ, Ruch W, Chideckel E et al. (1974) Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184:482–484

    Article  PubMed  CAS  Google Scholar 

  44. Konturek SJ, Tasler J, Obtulowiew W (1976) Effect of growth hormone release inhibiting hormone on hormones stimulating exocrine panceatic secretion. J Clin Invest 58:1–6

    Article  PubMed  CAS  Google Scholar 

  45. Konturek SJ, Cieszkowski M, Bilski J, Konturek J, Bielanski W, Schally AV (1985) Effects of cyclic hexapeptide analogue of somatostatin on pancreatic secretion in dogs. Proc Soc Exp Biol Med 178:68–72

    PubMed  CAS  Google Scholar 

  46. Konturek SJ, Bilski J, Jaworek J, Tasler J, Schally AV (1988) Comparison of somatostatin and its highly potent hexa- and octapeptide analogues on exocrine and endocrine pancreatic secretion. Proc Soc Exp Biol Med 187:241–249

    PubMed  CAS  Google Scholar 

  47. Krejs GJ, Browne R, Raskin P (1980) Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water and electrolytes. Gastroenterology 78:26–31

    PubMed  CAS  Google Scholar 

  48. Kutz K, Nuesch E, Rosenthaler J (1986) Pharmacokinetics of SMS 201–995 in healthy subjects. Scand J Gastroenterol 21[Suppl 119]:65–72

    Article  Google Scholar 

  49. Lankisch PG, Arnold R, Creutzfeldt W (1975) Wirkung von Somatostatin auf die Betazol-stimulierte Magensekretion und die Carbachol-stimulierte Pankreassekretion und die Gallenblasenkontraktion des Menschen. Dtsch Med Wochenschr 100:1797–1800

    Article  PubMed  CAS  Google Scholar 

  50. Lankisch PG, Koop H, Winckler K, Fölsch UR, Creutzfeldt W (1977) Somatostatin therapy of acute experimental pancreatitis. Gut 18:713–716

    Article  PubMed  CAS  Google Scholar 

  51. Layer P, Boekstegers A, Müller MK, Lotte A, Goebell H (1987) Cyclical interdigestive pancreatic secretion in response to physiologic doses of somatostatin-14 in humans. Gastroenterology 92:1495

    Google Scholar 

  52. Lembcke B, Creutzfeldt W, Schlieser S, Ebert R, Shaw C, Koop I (1987) Effect of the somatostatin analogue Sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 36:108–124

    Article  PubMed  CAS  Google Scholar 

  53. Lennon JR, Sircos W, Bloom SR et al. (1975) Investigation and treatment of a recurrent vipoma. Gut 16:821–822

    Article  PubMed  CAS  Google Scholar 

  54. Lightman SL, Fox P, Dunne MJ (1986) The effect of SMS 201–995, a long- acting somatostatin analogue, on anterior pituitary function in healthy male volunteers. Scand J Gastroenterol 21[Suppl 119]:84–95

    Article  Google Scholar 

  55. Lin TM, Evans DC, Shaar CJ, Root MA (1983) Action of somatostatin on stomach, pancreas, gastric mucosal blood flow and hormones. Am J Physiol 244:G40-G45

    PubMed  CAS  Google Scholar 

  56. Limberg B, Kommereil B (1980) Treatment of acute pancreatitis with somatostatin. N Engl J Med 303:284

    PubMed  CAS  Google Scholar 

  57. Luft R, Efendic S, Hökfelt T, Johansson O, Arimura A (1974) Immuno- histochemical evidence for the localization of somatostatin-like immunoreactivity in a cell population of the pancreatic islets. Med Biol 52:428–430

    PubMed  CAS  Google Scholar 

  58. Mann NS, Mauch MJ (1981) Inhibitory effect of cycloheximide, somatostatin and 5-aza cytidine on acute experimental pancreatitis. Am J Proctology 32:24–32

    CAS  Google Scholar 

  59. Maton PN, O’Dorisio TM, Howe BA, McArthur KE, Howard JM, Cherner JA, Malarkey TB, Collen MJ, Gardner JD, Jensen RT (1985) Effect of a long-acting somatostatin analogue (SMS 201–995) in a patient with pancreatic cholera. N Engl J Med 312:17–21

    Article  PubMed  CAS  Google Scholar 

  60. Mcintosh CHS (1985) Gastrointestinal somatostatin: distribution, secretion and physiological significance. Life Sei 37:2043–2058

    Article  CAS  Google Scholar 

  61. Meissner C, Thum C, Beischer W, Winkler G, Schröder KE, Pfeiffer EF (1975) The antidiabetic action of somatostatin - assessed by artificial pancreas. Diabetes 24:988–996

    Article  PubMed  CAS  Google Scholar 

  62. Müller MK, Kessel B, Hütt T, Layer P, Goebell H (1988) Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused stomach and pancreas preparation. Pancreas 3:303–310

    Article  PubMed  Google Scholar 

  63. Ohe M, Layer P, Wollny C, Beglinger C, Goebell H (1989) Effects of physiological doses of somatostatin-28 on cyclical interdigestive pancreatic secretion and upper gastrointestinal motility in humans. Gastroenterology 96:A374

    Google Scholar 

  64. Orci L, Baetens D, Ravazzola M, Stefan Y, Malaisse-Lagae F (1976) Pancreatic polypiptide and glucagon: non-random distribution in pancreatic islets. Life Sei 19:1811–1815

    Article  CAS  Google Scholar 

  65. O’Shaughnessy DJ, Long RG, Adrian TE et al. (1985) Somatostatin-14 modulates postprandial glucose levels and release of gastrointestinal and pancreatic hormones. Digestion 31:234–242

    Article  PubMed  Google Scholar 

  66. Patel YC, Wheatley T (1983) In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat. Endocrinology 112:220–225

    Article  PubMed  CAS  Google Scholar 

  67. Pearse AG (1980) The APUD concept and hormone production. Clin Endocrinol Metab 9:211–222

    Article  PubMed  CAS  Google Scholar 

  68. Penman E, Wass JAH, Medback S et al. (1981) Response of circulating immunoreative somatostatin to nutritional stimuli in normal subjects. Gastroenterology 81:692–699

    PubMed  CAS  Google Scholar 

  69. Penman E, Wass JAH, Butler MG et al. (1983) The distribution and characterization of immunoreactive somatostatin in human gastrointestinal tract. Regulatory Peptides 7:53–65

    Article  PubMed  CAS  Google Scholar 

  70. Pevet P, Ebels I, Swaab DF, Mud MT, Arimura A (1980) Presence of AVT- alpha-MSH- LHRH- and somatostatin-like compounds in the rat pineal gland and their relationship with the UM05R pineal fraction. An immunochemical study. Cell Tissue Res 206:341–353

    PubMed  CAS  Google Scholar 

  71. Pless J, Bauer W, Briner U, Doepfner W, Marbach P, Maurer R, Petcher TJ, Reubi J-C, Vonderscher J (1986) Chemistry and pharmacology of SMS 201–995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol 21[Suppl 119]:54—64

    Google Scholar 

  72. Polonsky KS, Jaspan JB, Berelowitz M, Emmanouel DS, Dhorajiwala J (1981) Hepatic and renal metabolism of somatostatin-like immunoreactivity. J Clin Invest 68:1149–1157

    Article  PubMed  CAS  Google Scholar 

  73. Polonsky KS, Shoelson SE, Docherty HM (1983) Plasma somatostatin-28 increases in response to feeding in man. J Clin Invest 71:1514–1518

    Article  PubMed  CAS  Google Scholar 

  74. Pradayrol L, Jornvall J, Mutt V, Ribet A (1980) N-terminally extended somatostatin: The primary structure of somatostatin-28. FEBS Lett 109:55–58

    Google Scholar 

  75. Primrose JN (1990) Octreotide in the treatment of the dumping syndrome. Digestion 45[Suppl l]:49–59

    Article  PubMed  Google Scholar 

  76. Regal H, Fink M, Luger T, Ogris E, Irsigler K (1977) Suppression der endokrinen und exokrinen Pankreasfunktion durch Somatostatin beim Menschen unter Stimulation durch Sekretin und Cholecystokinin- Pankreozymin. Wien Klin Wochenschr 89:580–586

    PubMed  CAS  Google Scholar 

  77. Reichlin S (1983) Somatostatin. N Engl J Med 309:1556–1563

    Article  PubMed  CAS  Google Scholar 

  78. Ruggere MD, Patel Y (1985) Somatostatin metabolism by the isolated rat lung. Endocrinology 117:1870–1873

    Article  PubMed  CAS  Google Scholar 

  79. Samnegard H, Tyden G, Thulin L, Friman L, Uden R (1980) Effect of somatostatin on regional splanchnic blood flows in man. Angiographic studies. Acta Chir Scand [Suppl] 500:71–73

    CAS  Google Scholar 

  80. Sanchez D, Sanchez A, Zurdo JR, Arriaza R, Chimpen V, Portugal J (1988) Pancreatitis aguda: Estudio clinico y terapeutico. Valoracion de la eficacia de Somatostatina. Ann Med Intern 3:40

    Google Scholar 

  81. Schally AV, Cai R-Z, Torres-Aleman I, Redding TW, Szoke B, Fu D, Hierowski MT, Colaluca J, Konturek SJ (1986) Endocrine, gastrointestinal and antitumor acitivity of somatostatin analogues. In: Moody TW (ed) Neural and endocrine peptides and receptors. Plenum, New York, pp 73–88

    Google Scholar 

  82. Schauder P, Mcintosh C, Arends J, Arnold R, Frerichs H, Creutzfeldt W (1977) Somatostatin and insulin release from isolated rat pancreatic islets in response to D-glucose, 1-leucine, alpha-ketoisocaproic acid or D- glyceraldehyde: evidence for a regulatory role of adenosine-3’,5’-cyclic monophosphate. Biochem Biophys Res Commun 75:630–635

    Article  PubMed  CAS  Google Scholar 

  83. Schlarman DE, Beinfeld MC, Andrus C, Kaminski DL (1987) Effects of somatostatin on acute canine experimental pancreatitis. Intern J Pancreatol 2:247–255

    CAS  Google Scholar 

  84. Schöndube S, Klempa I, Baca I, Menzel J (1987) Nekrotisierende Pankreatitis - ein Beitrag zur studiengerechten operativen Therapie (abstract). Österreichische Gesellschaft für Chirurgie, Lanz

    Google Scholar 

  85. Schusdziarra V (1980) Somatostatin - a regulatory modulator connecting nutrient entry and metabolism. Horm Metab Res 12:563–577

    Article  PubMed  CAS  Google Scholar 

  86. Schwedes U, Althoff PH, Klempa I et al. (1979) Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res 11:655–661

    Article  PubMed  CAS  Google Scholar 

  87. Scott NA, Finnegan S, Irving MH (1990) Octreotide and gastrointestinal fistulae. Digestion 45[Suppl 1]:66—71

    Google Scholar 

  88. Shen LP, Pictet R, Rutter W (1982) Human somatostatin I: Sequence of the cDNA. Proc Natl Acad Sei USA 79:4575–4579

    Article  CAS  Google Scholar 

  89. Seal A, Yamada T, Debas H et al. (1982) Somatostatin-14 and -28: Clearance and potency on gastric function in dogs. Am J Physiol 243.G97–102

    PubMed  CAS  Google Scholar 

  90. Siler TM, Yen SSC, Vale W, Guillemin R (1974) Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. J Clin Endocr Metab 38:742–745

    Article  PubMed  CAS  Google Scholar 

  91. Singh M (1986) Effect of somatostatin on amylase secretion from in vivo and in vitro rat pancreas. Dig Dis Sei 31:506–512

    Article  CAS  Google Scholar 

  92. Soll AH, Amirian DA, Park J, Elashoff JD, Yamada T (1985) Cholecystokinin potently releases somatostatin from canine fündic mucosal cells in short-term culture. Am J Physiol 248:G569–573

    PubMed  CAS  Google Scholar 

  93. Stöckmann F, Richter G, Lembcke B, Conlon JM, Creutzfeldt W (1986) Long-term treatment of patients with endocrine gastrointestinal tumours with the somatostatin analogue SMS 201–995. Scand J Gastroenterol 21[Suppl 119]:230—237

    Google Scholar 

  94. Stöckmann F, Creutzfeldt W (1988) Behandlung gastrointestinaler neuroendokriner Tumoren mit dem Somatostatin-Analog Octreotide (Sandostatin). Z Gastroenterol 26:665–675

    PubMed  Google Scholar 

  95. Susini C, Esteve JP, Bommelaer G, Vaysse N, Ribet A (1978) Inhibition of exocrine pancreatic secretion by somatostatin in dogs. Digestion 18:384–393

    Article  PubMed  CAS  Google Scholar 

  96. Susini C, Esteve JP, Vaysse N, Pradayrol L, Ribet A (1980) Somatostatin 28: Effects on exocrine pancreatic secretion in conscious dogs. Gastroenterology 79:720–724

    PubMed  CAS  Google Scholar 

  97. Taborsky G, Ensinck J (1983) Extraction of somatostatin by the pancreas. Endocrinology 112:303–307

    Article  PubMed  CAS  Google Scholar 

  98. Usadel KH, Uberla KK, Leuschner U (1985) Treatment of acute pancreatitis with somatostatin: Results of the multicenter double-blind trial (APTS-Study). Dig Dis Sei 30:992

    Google Scholar 

  99. Vaysse N, Chayvialle A, Pradayrol L et al. (1981) Somatostatin-28: comparison with somatostatin-14 for plasma kinetics and low-dose effects on the exocrine pancreas in dogs. Gastroenterology 81:700–706

    PubMed  CAS  Google Scholar 

  100. Veber DF, Freidinger RM, Perlow S, Paleveda WJ, Holly FW, Strachan RG, Nutt RF, Arison BH, Homnick C, Randall WC, Glitzer MS, Saperstein R, Hirschmann R (1981) A potent cyclic hexapeptide analogue of somatostatin. Nature 292:55–58

    Article  PubMed  CAS  Google Scholar 

  101. Wdowinski JM, Schwedes U, Faulstich H et al. (1981) Beneficial effect of somatostatin in phalloidin-intoxicated rats. Influence on survival rate, biochemical and morphological data, and 3H-demethyl-phalloin absorption rate by the liver. Res Exp Med 178:155–163

    Article  CAS  Google Scholar 

  102. Whitehouse I, Beglinger C, Fried M, Gyr K (1984) The effect of an octapeptide somatostatin analogue (SMS 201–995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: A comparative study in man. Hepatogastroenterol 31:227–229

    CAS  Google Scholar 

  103. Williams ST, Woltering EA, O’Dorisio TM, Fletcher WS (1989) Effect of octreotide acetate on pancreatic exocrine function. Am J Surg 157:459–462

    Article  PubMed  CAS  Google Scholar 

  104. Yamada T, Soil AH, Park J, Elashoff J (1984) Autonomic regulation of somatostatin release. Studies with primary cultures of canine fundic mucosal cells. Am J Physiol 247:G567–573

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin II, Universität Ulm, Robert-Koch-Straße 8, W-7900, Ulm, Germany

    P. Malfertheiner

Authors
  1. T. P. Kemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Büchler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Malfertheiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Allgemeine Chirurgie, Universitätsklinik Ulm, Steinhövelstraße 9, W-7900, Ulm, Germany

    H. G. Beger  & M. Büchler  & 

  2. Abteilung Innere Medizin II, Universitätsklinik Ulm, Robert-Koch-Straße 8, W-7900, Ulm, Germany

    P. Malfertheiner

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kemmer, T.P., Büchler, M., Malfertheiner, P. (1993). Effects of Somatostatin and Octreotide on Pancreatic Function. In: Beger, H.G., Büchler, M., Malfertheiner, P. (eds) Standards in Pancreatic Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77437-9_77

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77437-9_77

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77439-3

  • Online ISBN: 978-3-642-77437-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation